Trotta Matteo 4
4 · INCYTE CORP · Filed Jul 17, 2024
Insider Transaction Report
Form 4
INCYTE CORPINCY
Trotta Matteo
EVP, GM, Dermatology US
Transactions
- Award
Common Stock
2024-07-15+2,646→ 10,474 total - Award
Employee Stock Option (right to buy)
2024-07-15+5,921→ 5,921 totalExercise: $64.25Exp: 2034-07-14→ Common Stock (5,921 underlying)
Footnotes (3)
- [F1]Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years, subject to the employee's continued service with the issuer through the applicable vesting dates. The RSUs may be settled only for shares of common stock on a one-for-one basis.
- [F2]Including the July 15, 2024 grant, this includes an aggregate of 10,474 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- [F3]The July 15, 2024 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.